Lexicon Pharmaceuticals, Inc. Soared
Tue, Dec 08, 2020 at 05:30 PM
Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ) rocketted at $3.08, representing a gain of 78%. On Mon 07 Dec 20, LXRX:NASDAQ hit a New 2-Week High of $1.73. The stock got featured on our News Catalysts scanner on Mon 16 Nov 20 at 10:54 AM in the 'MISCELLANEOUS' category. From Mon 23 Nov 20, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Tue 17 Nov 20 at $2.38 with a volume of 102M+, and its share price has been moving sideways in recent weeks.
About Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ)
Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.
Top 10 Gainers:
- NGAC (NGAC:NASDAQ), 2639.47%
- Curis, Inc. (CRIS:NASDAQ), 354.86%
- MAAC (MAAC:NASDAQ), 100%
- Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ), 78.03%
- IGM Biosciences, Inc. (IGMS:NASDAQ), 57.75%
- Mammoth Energy Services, Inc. (TUSK:NASDAQ), 57.14%
- Blonder Tongue Laboratories, Inc. (BDR:NYSEMKT), 45.83%
- Liquidity Services, Inc. (LQDT:NASDAQ), 41.5%
- Stitch Fix, Inc. (SFIX:NASDAQ), 39.24%
- NeuroMetrix, Inc. (NURO:NASDAQ), 39.07%